Duchenne's Muscular Dystrophy (DMD) Terminated Phase 2 Trials for Halofuginone (DB04866)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01978366Open Label Extension Study of HT-100 in Patients With DMDTreatment
NCT02525302HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02Treatment